HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rivka Ofir Selected Research

9-acetamido-coumestrol

9/2013Aerobic iron-based cross-dehydrogenative coupling enables efficient diversity-oriented synthesis of coumestrol-based selective estrogen receptor modulators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rivka Ofir Research Topics

Disease

6Neoplasms (Cancer)
07/2018 - 05/2005
6Neurodegenerative Diseases (Neurodegenerative Disease)
05/2017 - 11/2006
2Lymphoma (Lymphomas)
07/2018 - 07/2018
2Neuroblastoma
06/2018 - 05/2017
2Alzheimer Disease (Alzheimer's Disease)
06/2017 - 05/2017
2Atrophy
10/2010 - 11/2006
1Schizophrenia (Dementia Praecox)
01/2018
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2017
1Brain Injuries (Brain Injury)
03/2016
1Breast Neoplasms (Breast Cancer)
09/2013
1Acute Erythroblastic Leukemia (Erythroleukemia)
11/2012
1Diarrhea
05/2012
1Meconium Ileus
05/2012
1Neuroinflammatory Diseases
10/2011
1Myopia
09/2011
1Cystic Fibrosis (Mucoviscidosis)
11/2010
1Dehydration (Water Stress)
11/2010
1Weight Gain
11/2010
1Starvation
06/2009
1Overweight
02/2009
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
02/2009
1Birk-Barel Mental Retardation Dysmorphism Syndrome
08/2008
1Epidermolysis Bullosa
04/2008
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
04/2008
1Epidermolysis bullosa with pyloric atresia
04/2008
1Arthrogryposis
09/2007
1Leukoencephalopathies
11/2006
1Seborrhea-Like Dermatitis with Psoriasiform Elements
07/2006
1Anophthalmos (Anophthalmia)
09/2004
1Microphthalmos
09/2004
1Cataract (Cataracts)
09/2004
1Coloboma (Colobomas)
09/2004
1Muscular Dystrophies (Muscular Dystrophy)
01/2004
1Type 2I Limb-Girdle Muscular Dystrophy
01/2004

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
07/2018 - 07/2006
4achillolide AIBA
06/2018 - 02/2015
3SesquiterpenesIBA
07/2018 - 05/2017
3LactonesIBA
07/2018 - 05/2017
2Caspase 3 (Caspase-3)IBA
07/2018 - 07/2018
2Biological ProductsIBA
12/2014 - 09/2013
1Etoposide (VP 16)FDA LinkGeneric
07/2018
1Cisplatin (Platino)FDA LinkGeneric
07/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2018
1Complex MixturesIBA
07/2018
1Arginine (L-Arginine)FDA Link
01/2018
1Serine (L-Serine)FDA Link
01/2018
1Amyloid beta-PeptidesIBA
06/2017
1FlavonoidsIBA
05/2017
13,5,4'- trihydroxy- 6,7,3'- trimethoxyflavoneIBA
05/2017
1Glutamic Acid (Glutamate)FDA Link
05/2017
1Pharmaceutical PreparationsIBA
03/2016
1AntioxidantsIBA
12/2014
1CoumestrolIBA
09/2013
19-acetamido-coumestrolIBA
09/2013
1Estrogens (Estrogen)FDA Link
09/2013
1Estrogen ReceptorsIBA
09/2013
1GlobinsIBA
11/2012
1Enterotoxins (Enterotoxin)IBA
05/2012
1Guanylate Cyclase (Guanylyl Cyclase)IBA
05/2012
1Volatile Oils (Essential Oils)IBA
01/2012
1PhytochemicalsIBA
10/2011
12-oxoglutarate 3-dioxygenase prolineIBA
09/2011
1SaltsIBA
11/2010
1ChloridesIBA
11/2010
1kalopanax saponin IIBA
11/2010
1TriterpenesIBA
11/2010
1SaponinsIBA
11/2010
16-propylchromone-2-carboxylic acid (PCCA)IBA
10/2010
1SelenocysteineIBA
10/2010
1NitrogenIBA
06/2009
1Insulin (Novolin)FDA Link
02/2009
1OligonucleotidesIBA
02/2009
1Potassium Channels (Potassium Channel)IBA
08/2008
1Fibronectins (Fibronectin)IBA
04/2008
1IntegrinsIBA
04/2008
1Phosphatidylinositols (Phosphatidylinositol)IBA
09/2007
1Epidermal Growth Factor (EGF)IBA
09/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
09/2007
1IronIBA
11/2006
1Phospholipases (Phospholipase)IBA
11/2006
1ChromiumIBA
11/2006
1N-acetylaspartate (N-acetyl aspartate)IBA
11/2006
1TeaIBA
05/2005
1citral (neral)IBA
05/2005
1NucleotidesIBA
09/2004
1GlycosyltransferasesIBA
01/2004

Therapy/Procedure

2Drug Therapy (Chemotherapy)
07/2018 - 07/2018
1Therapeutics
07/2018